secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2021-12-16T23:59:59+00:00
Accession:  0001613103-21-000070
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chief Medical & Scientific Officer Richard Kuntz to retire April 29, 2022
-------------------------------------------------------------------------

- Richard Kuntz notified Medtronic on Dec 14, 2021 of retirement effective April 29, 2022.
- Kuntz served as SVP and Chief Medical & Scientific Officer and on executive committee since 2005.
- He leaves after over 15-year tenure at Medtronic and 40-year career as interventional cardiologist.
- Filing does not name a successor or interim replacement for the role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/0001613103-21-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/mdt-20211214.htm
  HTML page:      https://secwatch.observer/filing/0001613103-21-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer